Beta-Blocker, Lipid Treatment Increases With Cardiology Visits, GAO Finds
Executive Summary
Managed care organizations have a "unique opportunity" to increase use of beta-blockers and cholesterol-lowering drugs in post-heart attack patients, the General Accounting Office states in a recently released study of drug usage patterns by doctors providing regular follow-up treatment.